© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
July 23, 2019
Prescription benefits consultant Chris Robbins, chief executive of cer of Arxcel, describes the finger-pointing in Congress over lowering drug costs this way: “If it weren’t so true, it might be almost humorous.”
October 09, 2018
Ongoing access to diabetes self-management education and support, and promoting good medication adherence are among the keys to managing high blood glucose in patients with type 2 diabetes.
September 05, 2018
FDA has granted priority review designation for Merckâ€™s request for a supplemental biologics license application for pembrolizumab to treat Merkel cell carcinoma, a rare skin cancer.
May 07, 2018
Patients with diabetes taking canagliflozin achieved better glycemic control, were less likely to stop taking the medication, and were less likely to switch to another drug.
April 02, 2018
Besides tracking the Healthy Days metric, Humana has focused interventions around social determinants of health: food insecurity, loneliness, and social isolation.
June 12, 2017
The results of the ODYSSEY-Diabetes trials focused on alirocumab, an approved monoclonal antibody that prevents PCSK-9 protein from impairing the liver’s receptors, and that antibody's effect on type 2 diabetes (T2D).